GIFT Nifty Opening Update
GIFT Nifty opened today at 24,616.50. It is up 59.00 points (0.24%) from yesterday’s close of 24,634.50— so the trend is positive.
The domestic stock market is anticipated to commence on a positive note on Thursday, August 6. The GIFT NIFTY futures indicate that the NIFTY50 index is poised to open 47 points higher. The BSE list indicates that 165 companies are scheduled to report their June quarter (Q1 FY27) results on Thursday, August 6. The list features entities including LIC, Trent, Britannia Industries, Samvardhana Motherson International, Hero MotoCorp, Lupin, Siemens Energy India, Premier Energies, Apollo Tyres, NCC, Kirloskar Oil Engines, Emcure Pharmaceuticals, Reliance Power, Sonata Software, and Vikram Solar, among others.
Equities to Monitor:
- Hindalco shares are anticipated to attract attention on Thursday, August 5, subsequent to the earnings report of its wholly owned subsidiary, Novelis, for the June quarter (Q1 FY27). The increase was primarily attributable to elevated average aluminium prices, which were partially counterbalanced by a 5% decline in total rolled product shipments, totalling 916 kilotonnes. It was primarily influenced by an estimated negative shipment impact of 33 kilotonnes associated with the Oswego production disruption resulting from the fires in fiscal year 2026.
- PB Fintech, the operator of PolicyBazaar, reported a consolidated net profit increase of 92% year-on-year, reaching Rs 163 crore in the June quarter of FY27, up from Rs 85 crore in the corresponding quarter of the previous fiscal year, FY26. Revenue from operations experienced a significant increase of 40.1% year-on-year, reaching Rs 1,888.28 crore in the first quarter of FY27, compared to Rs 1,347.99 crore during the corresponding period of the previous fiscal year. Its top line has experienced a compound average growth rate of 51%, increasing from 239 crore in Q1 FY22.
- Biocon reported a remarkable 349.4% year-on-year growth in its consolidated net profit, reaching Rs 141.1 crore for the quarter under review, in contrast to Rs 31.4 crore in the first quarter of the 2025-26 fiscal year. In the June quarter of FY27, the company’s revenue from operations experienced a year-on-year increase of 10%, reaching Rs 4,336 crore, compared to Rs 3,941.9 crore during the same period of the previous fiscal year, as reported in a regulatory filing. The top-line growth was propelled by robust performance in the Biopharma sector, which experienced a revenue increase of 17% year-over-year. Recent biosimilar and generic product launches across key markets provided significant momentum for this support.
- Cummins India reported a standalone net profit of Rs 543 crore for the April-June quarter, reflecting an 8% decrease from Rs 589 crore in the corresponding period of the previous year. The power solutions provider’s total revenue from operations, encompassing sales from operations and other operating income, experienced an 18% year-on-year increase, reaching Rs 3,426 crore in Q1 FY27, up from Rs 2,907 crore in the corresponding period of the previous year. Cummins’ operating profit, also referred to as earnings before interest, taxes, depreciation, and amortisation, declined by nearly 2% year-on-year to Rs 617 crore, down from Rs 624 crore in the same period of the prior financial year.
- Berger Paints announced a 28% rise in its consolidated net profit, reaching Rs 404 crore for the first quarter of the financial year 2026-27 (Q1 FY27), compared to Rs 315 crore during the corresponding period last year. The company’s revenue from operations increased by 12% in the April-June period, reaching Rs 3,584 crore compared to Rs 3,201 crore in the same quarter of the previous year. On the operational front, Berger Paints’ earnings before interest, taxes, depreciation & amortisation for the quarter surged 15% to Rs 607 crore in Q1 FY27 from Rs 528 crore in the corresponding quarter for the previous fiscal year.
- Gland Pharma and Neuland Laboratories are poised to attract attention as the companies revealed on Wednesday a long-term strategic partnership for contract development and manufacturing aimed at enhancing sterile API production. Under the partnership, Gland Pharma will establish a dedicated sterile manufacturing suite for Active Pharmaceutical Ingredients utilised in microparticle depot products, as stated in a press release. The collaboration integrates Neuland’s advanced API development and manufacturing capabilities, encompassing proficiency in intricate chemistry, process development, and tailored manufacturing, alongside Gland Pharma’s extensive global sterile manufacturing expertise.
- Mindspace REIT reported a 28% increase in its net operating income to Rs 788 crore for the quarter ended June and announced a Rs 442 crore distribution to unitholders for the first quarter of this fiscal. The company leased 0.9 million sq ft of commercial space during the April-June period of the 2026-27 fiscal year. “We delivered year-on-year NOI growth of 27.8 per cent and a distribution of Rs 6.67 per unit, up 15.2% over the prior year. These results reflect the strength of our portfolio, the quality of our assets, and disciplined execution,” stated Ramesh Nair.